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significance of this study
What is already known about this 
subject?
 ► Since the COVID-19 pandemic, physical 
barriers to potentially reduce droplet 
and aerosol spread during endotracheal 
intubation have been described.
What this study adds?
 ► To our knowledge, this is the first physical 
barrier described for use in upper 
gastrointestinal endoscopy, and we have 
demonstrated its efficacy in vitro, and its 
clinical utility in a small case series.
How might it impact on clinical 
practice in the foreseeable future?
 ► Use of such a device may become routine 
in upper gastrointestinal endoscopy to 
reduce the risk of nosocomial infection, 
but further studies on both generalisability 
and efficacy are required.
AbstrAct
Background During the COVID-19 pandemic, 
aerosol- generating procedures such as upper 
gastrointestinal endoscopy (UGIE) have been 
considered high risk. We designed a novel 
acrylic box (endoscopy box (EBOX)) with 
the intention of limiting aerosol and droplet 
spread during such procedures. We evaluated 
clinical utility, impact on the endoscopy team 
and also assessed the impact of the EBOX on 
macroscopic droplet spread from a simulated 
cough during UGIE.
Methods Clinical utility was evaluated 
prospectively via EBOX use on 15 patients 
undergoing endoscopic retrograde 
cholangiopancreatography (13) or endoscopic 
ultrasound (2). Feedback was recorded from the 
endoscopy team regarding ease of positioning, 
impact of the EBOX on procedural performance 
and cleaning. A cough was simulated via 
explosion of a hyperinflated balloon containing 
0.75 mL of ultraviolet disclosing lotion within 
the oral cavity of a mannequin, with and 
without the EBOX. Macroscopic spread was 
then evaluated with a ultraviolet torch.
Results Three endoscopists and the team 
members found that the EBOX did not hamper 
the procedure and felt it was a useful adjunct 
to full personal protective equipment (PPE). 
Simulated cough without the EBOX identified 
macroscopic spread up to 2.3 m away from 
the patient’s mouth as well as onto key areas 
such as the exposed neck of the endoscopist, 
which is not considered in current PPE guidance. 
Simulated cough using the EBOX significantly 
reduced macroscopic spread onto key areas of 
the healthcare workers.
Conclusions The EBOX is a valuable adjunct to 
recommended PPE for UGIE, but still allows these 
procedures to be performed in the standard 
manner.
IntroductIon
During the COVID-19 pandemic, many 
healthcare workers (HCW) have lost their 
lives, some of which is no doubt related 
to direct patient contact.1 2 Protection of 
healthcare staff remains of paramount 
importance in combating the crisis. Inter-
ventional medical procedures that have 
the potential to generate droplet and 
aerosols have the potential to put HCWs 
at particularly high risk.3 4
Upper gastrointestinal endoscopy 
(UGIE) including endoscopic retrograde 
cholangiopancreatography (ERCP) and 
endoscopic ultrasound (EUS) is consid-
ered to be an aerosol- generating proce-
dure (AGP), and current guidance requires 
full personal protective equipment (PPE) 
with as a minimum an FFP3 or N95 
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Figure 1 Simulated patient with EBOX in place (A), with the cranial drapes in place (B) and with the side operators drapes in place (C).
mask.5 6 Other protective equipment is also required 
including a full surgical gown covering the arms, torso 
and thighs, a plastic apron, face visor and gloves. The 
latter protect against droplets generated during intu-
bation and extubation, particularly from retching and 
coughing.7 8
The extent of droplet spread onto the PPE and 
elsewhere is not known during UGIE but it is estab-
lished that doffing errors can occur leading to self- 
contamination.9 Droplet spread is likely to occur at 
various stages of UGIE but particularly, during intuba-
tion and extubation.
The authors became aware of the  intubationbox. 
com project in the USA (personal communication, 
Prof Trisha Greenhalgh, CEBM Oxford), which has 
subsequently been published.10 Embedded in the 
website was a video of an experiment to simulate a 
cough during endotracheal intubation, demonstrating 
the effectiveness of a physical barrier.11 We had a box 
built (DIPEC Plastics, Cardiff) to the exact specifica-
tion on the website. Feedback from the anaesthetists 
was highly variable, but the majority were concerned 
with the relatively limited access and instability of the 
box on the bed or trolley.
With this in mind, our aim was to develop a physical 
barrier to reduce the amount of droplet spread onto 
the PPE of HCW during UGIE. Taking the stability 
and access issues into consideration, a new proto-
type box was designed and built with practical clinical 
utility in mind for UGIE procedures. Following feed-
back from endoscopy nursing staff and radiographic 
staff, a second prototype was built–The endoscopy 
box (EBOX). The EBOX, although open on its under-
side, has inward facing flanges which allow a sheet of 
acrylic to be inserted after placement. This sits over 
the flange but under the patient’s head thus stabilising 
the box (preventing instability issues of the previous 
design). There are access ports cut into the acrylic box 
at the head end for the assistant and on the side for the 
endoscopist.
The purpose of this study is to:
 ► Describe a new device (EBOX) for UGIE which may 
protect healthcare workers during the COVID-19 
pandemic.
 ► Evaluate the effectiveness of the EBOX in containing 
droplets during a simulated cough, while evaluating the 
effectiveness of current PPE guidance with and without 
the EBOX.
 ► Evaluate the clinical utility of the EBOX in a small series 
of complex endoscopy procedures—ERCP and EUS.
Methods
We gained approval from the Medical Director of 
the Clinical Innovation Partnership between Cardiff 
University and Cardiff and Vale University Health 
Board, and the Executive Medical Director of Cardiff 
and Vale University Health Board to allow us to pursue 
this project with urgency during the COVID-19 
pandemic. We sought and followed the advice provided 
by the Infection Prevention and Control Department 
at the University Hospital of Wales regarding safe 
cleaning and storage of the EBOX.
clinical utility
The EBOX prototype is seen in figure 1A without appli-
cation of disposable drapes, figure 1B with draping of 
the assistants access window continuing to the cranial 
aspect of the endoscopist’s access and figure 1C with 
draping of the caudal end of the EBOX, containing the 
patient’s torso and continuing to the caudal aspect of 
the endoscopist’s access (3M Steri- Drape Fluoroscope 
Drape, 3M Medical Solutions Division, UK). This 
creates an inner pair of curtains at the endoscopist’s 
access window. When the patient and the drapes are 
in the procedural position, a final drape is placed over 
this window and an access hole cut, to accommodate 
the endoscopist’s right arm for intubation and extu-
bation. Detailed information regarding our current 
recommendations for set- up, draping and cleaning can 
be found at www. ebox. wales.
All clinical procedures in the study were performed 
between the 20 April and 7 May 2020. Following 
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Figure 2 UV droplets visible on the inside roof of endoscopy box.
prior verbal consent from 15 patients (13 ERCP, 2 
EUS), the box was placed in position and the proce-
dures performed in the usual fashion. Care was taken 
to cover the biopsy access channel with a swab, during 
guidewire exchange. At the end of each procedure, the 
EBOX was placed on the floor of the room, and the 
whole room was left fallow for 1 hour according to 
local protocol. The EBOX was subsequently cleaned; 
the drapes were rolled with the contaminated side on 
the inside before removal and the EBOX cleaned with 
Clinell wipes for visible contamination, followed by 
Actichlor Plus solution (Ecolab, UK) at 10 000 ppm 
according to local protocols.
Verbal feedback from the patients and endoscopy 
nursing staff for all procedures, and radiographic staff 
for ERCP, was then obtained. Further feedback was 
obtained from another two endoscopists who used the 
EBOX for three cases.
simulated cough experiment
The laboratory study was performed on 27 April 
2020. An endoscopy training mannequin (AC4, OGI 
Phantom, Adam, Rouilly, UK) was positioned in the 
usual left lateral position for UGIE. A cholangiogram 
catheter with a Luer lock at the caudal end (Taut, 
Teleflex Medical Europe) was fitted with a balloon 
at the open cranial end containing 0.75 mL of UV 
disclosing lotion (GlitterBug Potion, Brevis Corpora-
tion, USA). Using biopsy forceps passed retrogradely 
up the oesophagus, the catheter was backloaded into 
the pharynx of the mannequin, followed by visual 
confirmation of the correct position with white and 
UV light. A 50 mL syringe containing air was attached 
to the Luer lock and inflated until the balloon burst, 
crudely simulating a cough. This was performed with 
the endoscopist and airway assistant wearing the 
recommended PPE as described in the introduction 
with the addition of a surgical hat. Prior to any simu-
lated cough, both operators were assessed with UV 
light in a darkened room for any unexpected contami-
nation by UV disclosing solution.
The simulated cough was then performed with and 
without the EBOX in place, with both operators’ arms 
inside the EBOX in the usual UGIE position. The 
spread of droplets following the balloon burst was illu-
minated with UV light in a darkened room to assess 
the distribution of the UV disclosing lotion.
results
clinical utility
The box was stable in all of the procedures undertaken 
with good patient acceptability on an X- ray fluoros-
copy table for ERCP and a standard trolley for EUS. 
The patients were reassured by positioning them first 
without the EBOX, then sliding the EBOX in place 
before applying the drapes. Drape application took 
less than 1 min by the final case in the series, as the 
technique evolved. The endoscopist and the airway 
assistant found no impairment to standard practice. 
Fluoroscopy images during ERCP could be obtained, 
although careful repositioning of the EBOX was 
required to ensure the top of the liver could be encom-
passed in the field of view. We rotated the image inten-
sifier from portrait to landscape, to allow better posi-
tioning of the intensifier during ERCP.
All patients received conscious sedation (Midaz-
olam and Fentanyl), delivered via an extension tube 
exiting the caudal end of the EBOX. Patient tolerance 
of the procedure was not impaired, and all cases were 
successfully completed. No patients described feeling 
claustrophobic while in the EBOX.
simulated cough experiment
There was no prior contamination by UV disclosing 
solution on the EBOX and drapes, either operator or 
the surrounding environment.
With the eboX in position
UV disclosing lotion was present on the internal 
surfaces of the EBOX and drapes particularly on the 
endoscopist’s side but also on the airway assistant’s 
side and the roof of the EBOX (figure 2).
UV disclosing lotion was also present on the right 
forearm and glove of the endoscopist, and the left 
forearm and glove of the airway assistant which were 
inside the EBOX. No UV disclosing lotion was seen on 
the left arm of the endoscopist outside the EBOX, or 
the right arm of the airway assistant inside the EBOX 
but behind the head.
No UV disclosing lotion was seen on the upper arms, 
torso, visor, head cover or mask of either operator. A 
small amount of UV disclosing lotion was seen on the 
lower aspect of the gown of both operators, presum-
ably via the inferior aspect of the drapes which were 
not fixed. No UV disclosing lotion was seen on unpro-
tected skin, in particular, the neck of the endoscopist 
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Figure 3 UV droplet contamination over gown, exposed neck 
and under visor onto facemask following simulated cough without 
endoscopy box (arrows highlight macroscopic contamination).
and airway assistant. No UV disclosing lotion was 
visible in the local environment.
Without the eboX in position
Following the simulated cough, UV disclosing lotion 
was present on the forearms, upper arms, upper and 
lower torso, and visor of both operators. It was present 
on both gloves of the endoscopist, the control wheels 
of the endoscope and the left glove of the airway assis-
tant. There was a significant volume of UV disclosing 
lotion on the uncovered neck of the endoscopist, under 
the full face visor onto the face mask (figure 3). There 
was no UV disclosing lotion on the head of either 
operator. Further UV disclosing lotion was seen in the 
surrounding environment up to 2.3 m away.
dIscussIon
This study has demonstrated two major findings; the 
EBOX is practical for clinical use, and is effective in 
significantly containing macroscopic droplet spread 
during a simulated cough.
In order to maximise clinical utility in the EBOX 
design, we noted the limitations described by Canelli et 
al, akin to the feedback received from our anaesthetic 
colleagues, and aimed to surpass these limitations.10 
Subsequently, others have described further limita-
tions but fortunately we had already addressed those 
which may be relevant to UGIE.12 We improved access 
by using plastic drapes over wide access ports in the 
acrylic, which allow greater freedom of movement by 
the operator when compared with small fixed circular 
holes for access. Stability of the EBOX was addressed 
by using the weight of the patient in the design as they 
rest on a support. This did not impair rapid removal of 
the box if there were an adverse event such as cardiac 
arrest. We rehearsed this with a volunteer in the EBOX 
and it could be removed in less than a second. Fortu-
nately, no such adverse events occurred in this small 
series.
We found that there was significant macroscopic 
droplet spread onto the endoscopist’s neck without 
the EBOX in place. At the point of simulated cough, 
the endoscopist was looking at an endoscopy monitor, 
in keeping with standard practice; therefore, the neck 
was slightly extended. This likely explains the distri-
bution of the UV disclosing lotion. Neck protection is 
not included in current Public Health England (PHE) 
PPE guidance for AGPs.6 If correct doffing procedures 
are followed to the letter, contamination on the HCW 
could remain. No neck protection or washing proto-
cols are in place in any guidance, as far as we know.
The EBOX did not completely abolish macroscopic 
droplet spread outside the box. UV disclosing lotion 
was seen on the lower gown of both operators with 
the EBOX in place, presumably due to the lack of fixa-
tion inferiorly. As a consequence, we have now modi-
fied our protocol to address this by fixing the lower 
drapes. We also believe that the cough being partially 
contained will cause a loss of momentum in the cough 
particle cloud, reducing distance travelled and poten-
tially the likelihood of any particle from settling.13
As we move into the deceleration and recovery 
phase of the pandemic, it is likely that more UGIE will 
be performed with anaesthetic throat spray only. From 
our experience, patients tend to gag and cough more 
in this situation. This may enhance the value of the 
box in protecting HCW. All of our procedures were 
performed with conscious sedation and all tolerated 
the presence of the EBOX well. Although further work 
on patient tolerance is required with UGIE using throat 
spray, the EBOX was in position and fully draped prior 
to delivery of sedation. Further studies are needed to 
evaluate generalisability, and these are in development 
in Wales.
There are limitations to this study: the lack of 
generalisability and the fact this remains a simulated 
cough but we are addressing the former, and further 
studies are required to evaluate the full efficacy. In the 
simulated cough experiment, we used a significantly 
smaller volume than previously described (0.75 mL of 
UV disclosing solution compared with 10 mL used by 
Canelli et al) in an effort to more realistically simulate 
a cough.10
While the findings from studies in Newcastle in 
the UK and Italy are encouraging for both the HCW 
community generally,14 and endoscopy specifically,15 
the authors in these studies also recognise the limita-
tions of their findings. COVID-19 is indiscriminate, 
and if this device saves the life of even one HCW, use 
of the EBOX is justified, particularly as it costs so little 
to produce (£60). It is reusable, and the cost of the 
disposable drapes per case is approximately £6. While 
the authors consider that the EBOX has significant 
potential clinical utility, it is important to stress that 
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this is an adjunct to full PPE for AGPs. Such PPE was 
worn by all HCW in the procedure room during the 
evaluation of clinical utility according to current PHE 
guidance. We feel that one of the primary benefits of 
the EBOX is the reduction in droplet load and limiting 
macroscopic droplet transfer onto key areas such as 
exposed areas of the head and neck, where doffing 
errors often take place.9
In conclusion, we have demonstrated the EBOX 
is a useful adjunct to full PPE for UGIE. It does not 
impair performance of the procedures, costs little and 
this study has exposed concerns regarding droplet 
spread onto the endoscopist which are not addressed 
by current PPE guidance for UGIE. We recognise that 
further evaluation work is required including the 
following:
 ► Evaluate generalisability of the EBOX in wider endo-
scopic practice by user feedback.
 ► Evaluate the role of the EBOX in containing and 
removing aerosol- generated particles as well as 
droplets.
 ► Evaluate overall efficacy of the EBOX in reducing viral 
transmission rates to HCWs.
However, the publication of the latest British Society 
of Gastroenterology guidance for the deceleration and 
recovery phase of the pandemic16 will increase the 
number of UGIE procedures, and the EBOX may have 
a valuable role to play.
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